BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17496005)

  • 1. Substitution of oral (18)F-FDG for intravenous (18)F-FDG in PET scanning.
    Nair N; Agrawal A; Jaiswar R
    J Nucl Med Technol; 2007 Jun; 35(2):100-4. PubMed ID: 17496005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients.
    Gelfand MJ; O'hara SM; Curtwright LA; Maclean JR
    Pediatr Radiol; 2005 Oct; 35(10):984-90. PubMed ID: 15988582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
    Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
    J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic observation of 18F-FDG uptake after oral administration in a healthy subject.
    Zhang K; Wang X; Hao L; Zhao Z; Han C
    J Nucl Med Technol; 2013 Jun; 41(2):78-80. PubMed ID: 23608073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
    Kumar R; Loving VA; Chauhan A; Zhuang H; Mitchell S; Alavi A
    J Nucl Med; 2005 Nov; 46(11):1819-24. PubMed ID: 16269595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG; Huang G; Liu JJ; Wan LR
    Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid scanning protocol for brain (18)F-FDG PET: a validation study.
    Chen WP; Matsunari I; Noda A; Yanase D; Yajima K; Takeda N; Yamada M; Minoshima S; Nishimura S
    J Nucl Med; 2005 Oct; 46(10):1633-41. PubMed ID: 16204713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
    Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
    J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necessity of a uniform start for scanning after FDG injection in brain PET study.
    Ishii K; Higashi Y; Tabata M; Miyaishi M; Mizutani T; Sasaki M
    Ann Nucl Med; 2006 May; 20(4):329-31. PubMed ID: 16856579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.